Skip to content

The Development and Evaluation of an E-Visit Program for the Management of Acne

The Development and Evaluation of an E-Visit Program for the Management of Acne

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00417456
Enrollment
151
Registered
2007-01-01
Start date
2005-10-31
Completion date
2007-12-31
Last updated
2012-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris

Keywords

Acne, Telemedicine, Dermatology

Brief summary

The purpose of this study is to test the efficacy, timeliness, and user satisfaction of an online E-Visit application that uses store-and-forward technology for acne patients requiring dermatologic care for their condition. Hypotheses: 1. That an E-Visit is an effective alternative to in-person clinic care for patients with mild to severe facial acne. 2. That providers and patients will be satisfied with this model. 3. That mean wait times for new and return visits will be reduced through the E-Visit model. 4. That this prototype for care will improve clinic workflow, offer additional patient access, and allow urgent cases to be seen earlier.

Detailed description

Across the United States, a geographically mal-distributed workforce of Dermatologists exists, a problem that is projected to worsen. Patient access to dermatologic care is threatened. The dermatology workforce shortage has resulted in long wait times for patients, especially new patient visits and acute care cases. Teledermatology has received much attention as a solution to the preceding problems. Teledermatology can reduce the burden of repeat office visits in chronic conditions by facilitating care from home. In this trial, a model incorporating store-and-forward technology is tested in general clinics while its impact on clinical outcomes, satisfaction, and wait times are studied. Comparison: After consent, study subjects are assigned a unique study number and randomly assigned to one of two groups: Group 1- The first group of subjects will have four (4) in-office visits spaced six weeks apart. Group 2- The second group will have four (4) e-visits spaced six weeks apart. At the end of study (after completion of 5th visit overall) all participants will complete a satisfaction survey.

Interventions

OTHEREvisit

Asynchronous,remote care delivery via a secure web platform

Conventional office-based care

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 12 or older * Diagnosis of mild to severe facial acne * Access to a credit card * Access to an Internet connection and a computer * Ability to image self * MA Blue Cross/ Blue Shield Coverage

Exclusion criteria

* Non-English speaking individuals * Patients taking Accutane for their acne * Impaired Physical ability to image self * Impaired Cognitive ability

Design outcomes

Primary

MeasureTime frame
Peer review of subject images using the Total Inflammatory Lesion Count at the end of active recruitment6 months

Secondary

MeasureTime frame
Subject satisfaction6 months
Physician satisfaction6 months
Timing of visitsongoing

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026